SOD1 and amyotrophic lateral sclerosis: The data shown in the present review present several limitations considering that most of the studies were performed in SOD1 G93A mice model at different disease phases (Mesnard et al., 2011; Ringer et al., 2013) and in brain samples of ALS decedents, representing the end-stage of the disease.